Over the past decade National Institutes of Health (NIH) has shaped its data-sharing policies to achieve two goals--maximize the value of research, and protect patient privacy and intellectual property. Now, NIH is seeking feedback on its plans to apply these aims to the sharing of genomics data.
NIH announced Wednesday that it is awarding three grants totaling more than $25 million over four years to support a national genomic sequencing database project, with the goal of advancing treatment for diseases like cancer, cardiovascular disease and metabolic disorders.
The NIH said it is freeing up $3.7 million in awards to boost training opportunities for graduate students and postdoctoral scholars pursuing careers in biomedical research.
NIH has rolled out a $45 million initiative to both identify new targets and test promising drugs for treating Alzheimer's disease, which affects as many as 5 million people un the U.S.
When President Obama unveiled the BRAIN Initiative in April, his speech was heavy on lofty rhetoric but light on detail. This week the team tasked with turning the grand vision into practical projects filed its first report, and placed strong emphasis on improving data storage, analysis and interpretation.
The Banner Alzheimer's Institute in Phoenix has landed a $33 million NIH grant to see if an anti-amyloid therapy can prevent the memory-wasting condition from getting a grip on patients.
The research community wasn't sure what to expect when President Obama first announced his plans for a public-private BRAIN Initiative in April. With the release of an interim report on Monday, an NIH work group has laid out some initial goals of the project.
Eli Lilly has found a new path into the hot rare-disease field. An NIH program has backed the Indianapolis-based drug giant's preclinical-stage research of a potential treatment for a hormone deficiency often caused by a genetic defect.
In the ongoing hunt to uncover new therapies for rare diseases, the NIH has selected four new preclinical drug development studies to support, the findings of which will be shared with other researchers.
Genia Technologies has landed a $5.3 NIH grant to advance its genome sequencing technology. The company will use the money in its work with partners at Columbia University and Harvard Medical school to fund more development of NanoTag, its nanopore-based DNA sequencing platform.